Skip to main content
Erschienen in: Lung 2/2018

12.02.2018 | COPD

Cardiovascular Studies in Patients with Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco

verfasst von: Rafael Golpe, Pilar Sanjuán-López, Irene Martín-Robles, Carlos González-Juanatey, Luis Pérez-de-Llano, José L. López-Campos

Erschienen in: Lung | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background and Objective

The cardiovascular effects of biomass smoke exposure in patients with chronic obstructive pulmonary disease are not well characterized, and few studies have assessed the possible differences between patients with disease caused by biomass smoke and tobacco. The aim of this study was to search for differences in cardiovascular variables between both types of the disease.

Methods

Twenty subjects (15 men, 5 women) with chronic obstructive pulmonary disease caused by tobacco were matched one to one for sex, age, and forced expiratory volume in 1 s to 20 patients with biomass-related disease. Echocardiography and carotid ultrasound studies were performed. Flow-mediated endothelium-dependent vasodilatation and endothelium-independent vasodilatation were also measured.

Results

There were no significant differences between groups in any of the echocardiographic variables, nor in the intima–media carotid thickness, the number of carotid plaques, or the percentage of endothelium-dependent or endothelium-independent vasodilation. A high percentage of patients in both groups showed an abnormal flow-mediated endothelium-dependent vasodilatation pattern.

Conclusion

The study does not support the hypothesis of a different cardiovascular effect of biomass or tobacco smoke exposure in patients with chronic obstructive pulmonary disease. Cardiovascular comorbidity should be assessed in patients with biomass-associated disease, similarly to subjects with tobacco-related disease.
Literatur
1.
Zurück zum Zitat Salvi S, Barnes PJ (2010) Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest 138:3–6CrossRefPubMed Salvi S, Barnes PJ (2010) Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest 138:3–6CrossRefPubMed
2.
Zurück zum Zitat Sin DD, Man SF (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107:1514–1519CrossRefPubMed Sin DD, Man SF (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107:1514–1519CrossRefPubMed
3.
Zurück zum Zitat Ruiz-Vera T, Pruneda-Álvarez LG, Ochoa-Martínez AC, Ramírez-GarcíaLuna JL, Pierdant-Pérez M, Gordillo-Moscoso AA et al (2015) Assessment of vascular function in Mexican women exposed to polycyclic aromatic hydrocarbons from wood smoke. Environ Toxicol Pharmacol 40:423–429CrossRefPubMed Ruiz-Vera T, Pruneda-Álvarez LG, Ochoa-Martínez AC, Ramírez-GarcíaLuna JL, Pierdant-Pérez M, Gordillo-Moscoso AA et al (2015) Assessment of vascular function in Mexican women exposed to polycyclic aromatic hydrocarbons from wood smoke. Environ Toxicol Pharmacol 40:423–429CrossRefPubMed
4.
Zurück zum Zitat Buturak A, GenÇ A, Ulus OS, Duygu E, Ökmen AS, Uyarel H (2011) Evaluation of the effects of chronic biomass fuel smoke exposure on peripheral endothelial functions: an observational study. Anadolu Kardiyol Derg 11:492–497PubMed Buturak A, GenÇ A, Ulus OS, Duygu E, Ökmen AS, Uyarel H (2011) Evaluation of the effects of chronic biomass fuel smoke exposure on peripheral endothelial functions: an observational study. Anadolu Kardiyol Derg 11:492–497PubMed
5.
Zurück zum Zitat Caravedo MA, Herrera PM, Mongilardi N, de Ferrari A, Davila-Roman VG, Gilman RH et al (2016) Chronic exposure to biomass fuel smoke and markers of endothelial inflammation. Indoor Air 26:768–775CrossRefPubMed Caravedo MA, Herrera PM, Mongilardi N, de Ferrari A, Davila-Roman VG, Gilman RH et al (2016) Chronic exposure to biomass fuel smoke and markers of endothelial inflammation. Indoor Air 26:768–775CrossRefPubMed
6.
Zurück zum Zitat Sertogullarindan B, Gumrukcuoglu HA, Sezgi C, Akil MA (2012) Frequency of pulmonary hypertension in patients with COPD due to biomass smoke and tobacco smoke. Int J Med Sci 9:406–412CrossRefPubMedPubMedCentral Sertogullarindan B, Gumrukcuoglu HA, Sezgi C, Akil MA (2012) Frequency of pulmonary hypertension in patients with COPD due to biomass smoke and tobacco smoke. Int J Med Sci 9:406–412CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. http://goldcopd.org/. Accessed 12 June 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. http://​goldcopd.​org/​. Accessed 12 June 2017
8.
Zurück zum Zitat Beevers G, Lip GYH, O’Brien E (2001) ABC of hypertension, 4th edn. BMJ Books, London Beevers G, Lip GYH, O’Brien E (2001) ABC of hypertension, 4th edn. BMJ Books, London
9.
Zurück zum Zitat Berger M, Haimowitz A, Van Tosh A, Berdoff RL, Goldberg E (1985) Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol 6:359–365CrossRefPubMed Berger M, Haimowitz A, Van Tosh A, Berdoff RL, Goldberg E (1985) Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol 6:359–365CrossRefPubMed
10.
Zurück zum Zitat Kircher BJ, Himelman RB, Schiller NB (1990) Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 66:493–496CrossRefPubMed Kircher BJ, Himelman RB, Schiller NB (1990) Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 66:493–496CrossRefPubMed
11.
Zurück zum Zitat Gonzalez-Juanatey C, Llorca J, Vazquez-Rodriguez TR, Diaz-Varela N, Garcia-Quiroga H, Gonzalez-Gay MA (2008) Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor α blocker therapy. Arthritis Care Res 59:1821–1824CrossRef Gonzalez-Juanatey C, Llorca J, Vazquez-Rodriguez TR, Diaz-Varela N, Garcia-Quiroga H, Gonzalez-Gay MA (2008) Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor α blocker therapy. Arthritis Care Res 59:1821–1824CrossRef
12.
Zurück zum Zitat Esper RJ, Nordaby RA, Vilariño JO, Paragano A, Cacharrón JL, Machado RA (2006) Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol 5:4CrossRefPubMedPubMedCentral Esper RJ, Nordaby RA, Vilariño JO, Paragano A, Cacharrón JL, Machado RA (2006) Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol 5:4CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N et al (2012) Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the Advisory Board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European stroke conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006 and Hamburg, Germany, 2011. Cerebrovasc Dis 34:290–296CrossRefPubMedPubMedCentral Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N et al (2012) Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the Advisory Board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European stroke conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006 and Hamburg, Germany, 2011. Cerebrovasc Dis 34:290–296CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Eickhoff P, Valipour A, Kiss D (2008) Determinants of systemic vascular function in patients with stable COPD. Am J Respir Crit Care Med 178:1211–1218CrossRefPubMed Eickhoff P, Valipour A, Kiss D (2008) Determinants of systemic vascular function in patients with stable COPD. Am J Respir Crit Care Med 178:1211–1218CrossRefPubMed
15.
Zurück zum Zitat Golpe R, Sanjuán-López P, Cano-Jiménez E, Castro-Añón O, Pérez de Llano LA (2014) Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch Bronconeumol 50:318–324CrossRefPubMed Golpe R, Sanjuán-López P, Cano-Jiménez E, Castro-Añón O, Pérez de Llano LA (2014) Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch Bronconeumol 50:318–324CrossRefPubMed
16.
Zurück zum Zitat Camp PG, Ramírez-Venegas A, Sansores RH, Alva LF, McDougall JE, Sin DD et al (2014) COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women. Eur Respir J 43:725–734CrossRefPubMed Camp PG, Ramírez-Venegas A, Sansores RH, Alva LF, McDougall JE, Sin DD et al (2014) COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women. Eur Respir J 43:725–734CrossRefPubMed
17.
Zurück zum Zitat Golpe R, Mateos-Colino A, Testa-Fernández A, Pena-Seijo M, Rodríguez-Enríquez M, González-Juanatey C et al (2016) Blood pressure profile and hypertensive organ damage in COPD patients and matched controls. The RETAPOC study. PLoS ONE 11(6):e0157932CrossRefPubMedPubMedCentral Golpe R, Mateos-Colino A, Testa-Fernández A, Pena-Seijo M, Rodríguez-Enríquez M, González-Juanatey C et al (2016) Blood pressure profile and hypertensive organ damage in COPD patients and matched controls. The RETAPOC study. PLoS ONE 11(6):e0157932CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Solleiro-Villavicencio H, Quintana-Carrillo R, Falfán-Valencia R, Vargas-Rojas MI (2015) Chronic obstructive pulmonary disease induced by exposure to biomass smoke is associated with a Th2 cytokine production profile. Clin Immunol 161:150–155CrossRefPubMed Solleiro-Villavicencio H, Quintana-Carrillo R, Falfán-Valencia R, Vargas-Rojas MI (2015) Chronic obstructive pulmonary disease induced by exposure to biomass smoke is associated with a Th2 cytokine production profile. Clin Immunol 161:150–155CrossRefPubMed
19.
Zurück zum Zitat Golpe R, Martín-Robles I, Sanjuán-López P, Cano-Jiménez E, Castro-Añón O, Mengual-Macenlle N et al (2017) Prevalence of major comorbidities in chronic obstructive pulmonary disease caused by biomass smoke or tobacco. Respiration 94:38–44CrossRefPubMed Golpe R, Martín-Robles I, Sanjuán-López P, Cano-Jiménez E, Castro-Añón O, Mengual-Macenlle N et al (2017) Prevalence of major comorbidities in chronic obstructive pulmonary disease caused by biomass smoke or tobacco. Respiration 94:38–44CrossRefPubMed
20.
Zurück zum Zitat Sandoval J, Salas J, Martínez-Guerra ML, Gómez A, Martínez C, Portales A et al (1993) Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation. Chest 103:12–20CrossRefPubMed Sandoval J, Salas J, Martínez-Guerra ML, Gómez A, Martínez C, Portales A et al (1993) Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation. Chest 103:12–20CrossRefPubMed
21.
Zurück zum Zitat Moran-Mendoza O, Pérez-Padilla JR, Salazar-Flores M, Vázquez-Alfaro F (2008) Wood smoke associated lung disease: a clinical, functional, radiological, and pathological description. Int J Tuberc Lung Dis 12:1092–1098PubMed Moran-Mendoza O, Pérez-Padilla JR, Salazar-Flores M, Vázquez-Alfaro F (2008) Wood smoke associated lung disease: a clinical, functional, radiological, and pathological description. Int J Tuberc Lung Dis 12:1092–1098PubMed
22.
Zurück zum Zitat Rivera RM, Cosio MG, Ghezzo H, Salazar M, Pérez-Padilla R (2008) Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis 12:972–977PubMed Rivera RM, Cosio MG, Ghezzo H, Salazar M, Pérez-Padilla R (2008) Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis 12:972–977PubMed
23.
Zurück zum Zitat Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE (2010) Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 65:956–962CrossRefPubMed Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE (2010) Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 65:956–962CrossRefPubMed
Metadaten
Titel
Cardiovascular Studies in Patients with Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco
verfasst von
Rafael Golpe
Pilar Sanjuán-López
Irene Martín-Robles
Carlos González-Juanatey
Luis Pérez-de-Llano
José L. López-Campos
Publikationsdatum
12.02.2018
Verlag
Springer US
Erschienen in
Lung / Ausgabe 2/2018
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-018-0095-9

Weitere Artikel der Ausgabe 2/2018

Lung 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.